A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli -related hemolytic uremic syndrome with neurological involvement
ConclusionsA “neurological score” may be a useful tool to drive the early treatment of CNS complications in STEC-HUS with eculizumab, although future perspective controlled studies are urgently needed to validate this therapeutic approach.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Brain | Children | Disability | Gastroenteritis | Gastroenterology | Hemolytic Uremic Syndrome (HUS) | Italy Health | MRI Scan | Neurology | Pediatrics | Study | Urology & Nephrology